Generelt udviste de patienter, der blev testet positive for IgG- antistoffer, øget tendens til at få infusionsrelaterede virkninger end de patienter, der ikke blev testet positive.
In general, patients who tested positive for IgG antibodies were more likely to have infusion-related events than those who did not test positive.